| 000 | 01774 a2200457 4500 | ||
|---|---|---|---|
| 005 | 20250515010611.0 | ||
| 264 | 0 | _c20060203 | |
| 008 | 200602s 0 0 eng d | ||
| 022 | _a1175-2203 | ||
| 024 | 7 |
_a10.2165/00129785-200505060-00004 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aCleary, John D | |
| 245 | 0 | 0 |
_aAntimycotic drug discovery in the age of genomics. _h[electronic resource] |
| 260 |
_bAmerican journal of pharmacogenomics : genomics-related research in drug development and clinical practice _c2005 |
||
| 300 |
_a365-86 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, N.I.H., Extramural; Review | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAntifungal Agents _xpharmacokinetics |
| 650 | 0 | 4 | _aCell Line |
| 650 | 0 | 4 | _aClinical Trials as Topic |
| 650 | 0 | 4 |
_aCytochrome P-450 Enzyme System _xgenetics |
| 650 | 0 | 4 | _aDrug Design |
| 650 | 0 | 4 | _aDrug Evaluation, Preclinical |
| 650 | 0 | 4 |
_aFungi _xdrug effects |
| 650 | 0 | 4 |
_aGene Expression Profiling _xmethods |
| 650 | 0 | 4 |
_aGenome, Fungal _xdrug effects |
| 650 | 0 | 4 |
_aGenomics _xmethods |
| 650 | 0 | 4 |
_aHistamine _xmetabolism |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aMembrane Transport Proteins _xgenetics |
| 650 | 0 | 4 |
_aMetabolic Detoxication, Phase II _xgenetics |
| 650 | 0 | 4 | _aMicrobial Sensitivity Tests |
| 650 | 0 | 4 |
_aMycoses _xdrug therapy |
| 650 | 0 | 4 | _aPharmacogenetics |
| 650 | 0 | 4 | _aPolymorphism, Genetic |
| 650 | 0 | 4 | _aSubstrate Specificity |
| 700 | 1 | _aWalker, Larry A | |
| 700 | 1 | _aHawke, Roy L | |
| 773 | 0 |
_tAmerican journal of pharmacogenomics : genomics-related research in drug development and clinical practice _gvol. 5 _gno. 6 _gp. 365-86 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.2165/00129785-200505060-00004 _zAvailable from publisher's website |
| 999 |
_c15957284 _d15957284 |
||